Reducing Sugar During Antibiotic Treatment Preserves Gut Bacteria Diversity

Researchers tracking 158 cancer patients undergoing stem cell transplants and antibiotic treatment discovered that high sugar consumption during antibiotic courses led to reduced gut microbiome diversity. The study analyzed over 40,000 food items with unprecedented nutritional precision by cross-referencing hospital meal orders with detailed ingredient information. Maintaining lower sugar intake while taking antibiotics appears to help protect the beneficial bacteria that support digestive and mental health.

The research benefited from an unusually rigorous data collection method. Participants in stem cell transplant programs recorded their meal consumption through hospital kitchen questionnaires over an extended period, allowing researchers to match dietary intake with stool sample analysis across more than 40,000 food items. This precision enabled scientists to identify specific nutritional patterns—particularly the 24 percent increased loss of bacterial diversity for every 100 grams of high-sugar consumption during antibiotic courses—that would be difficult to establish through typical nutrition studies relying on patient recall.

The mechanism appears to involve competitive advantage for harmful bacteria. When antibiotics eliminate most gut flora, remaining microbes compete for nutrients. Sugar-fermenting pathogens like Enterococcus faecium may gain an edge over beneficial bacteria that require fiber to recover, effectively disrupting the microbiome's recovery trajectory during a vulnerable period.